Table 2. Rates of 33 Self-Reported Medication Side Effects in the Treatment Phase.

Side Effect		0 mg (n = 16)	30 mg IR (n = 12)	30 mg SR (n = 10)
1.	Change in appetite	50.0	66.7	80.0
2.	Sleeping More	50.0	58.3	50.0
3.	Sleeping Less	18.8	33.3	70.0*
4.	More Anxious	18.8	33.3	50.0
5.	Less Anxious	6.3	33.3	50.0*
6.	More Unhappy	12.5	33.3	20.0
7.	Happier	75.0	83.3	90.0
8.	Coughing	62.5	66.7	70.0
9.	Trouble Concentrating	31.3	25.0	40.0
10.	Weight Changing	37.5	66.7	60.0
11.	More Angry	25.0	25.0	50.0
12.	Hands Shaking	0.0	0.0	20.0
13.	Diarrhea	12.5	8.3	40.0
14.	Constipation	18.8	8.3	30.0
15.	Nausea	12.5	16.7	20.0
16.	More Energy	50.0	58.3	60.0
17.	Less Energy	18.8	8.3	30.0
18.	Felt High	0.0	16.7	10.0
19.	Chills	0.0	16.7	10.0
20.	Fever	0.0	16.7	10.0
21.	Heart Beating Slower	6.3	16.7	20.0
22.	Heart Beating Faster	12.5	33.3	40.0
23.	Breathe Faster	12.5	50.0	40.0
24.	Dry Mouth	25.0	33.3	70.0
25.	Runny Nose	31.3	25.0	40.0
26.	Trouble with Eyes	37.5	33.3	60.0
27.	Increased Urination	50.0	50.0	60.0
28.	Drowsy	18.8	16.7	60.0
29.	Muscles/Bones Ache	12.5	33.3	50.0
30.	Felt Dizzy	6.3	8.3	30.0
31.	Sleeping Better	43.8	66.7	70.0
32.	Medication Too High	0.0	0.0	10.0
33.	Medication Too Low	18.8	33.3	50.0

Note. A total of 42 subjects entered the 8-week treatment phase, but 4 subjects did not provide side effects ratings before being dropped from the study in weeks 1 (n = 2) and 2 (n = 2) of treatment for protocol violations. Accordingly side effect ratings are available for 38 subjects. The rates of ever experiencing a side effect in the 8-week treatment periods are presented, collapsing across time due to low weekly endorsement rates.

^*p<. 05.